Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-human Phase I, Open-label, Multicentre Trial of i.v. Administrations of BI 4060107 in Patients With Unresectable Advanced and/or Metastatic Solid Tumours

NCT07827144 is registered in ClinicalTrials.gov with AIMEDBIO as lead sponsor.

NCT NCT07827144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07827144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-human Phase I, Open-label, Multicentre Trial of i.v. Administrations of BI 4060107 in Patients With Unresectable Advanced and/or Metastatic Solid Tumours
Lead sponsor
AIMEDBIO
Phase
Phase 1
Overall status
Recruiting
Start date
October 9, 2026
Completion date
May 13, 2030
Enrollment
90 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumours